Atlas Trials

Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer

Clinical trial NCT07189598 · RECRUITING

Trial details

NCT number
NCT07189598
Sponsor
Center Eugene Marquis
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
High Risk Prostate Cancer
Start date
2026-03-02
Primary completion
2033-04-01
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.